Research programme: diabetes protein therapeutics - Five Prime Therapeutics
Alternative Names: FPT 038Latest Information Update: 21 Apr 2021
At a glance
- Originator Five Prime Therapeutics
- Class Antibodies; Proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Diabetes mellitus